कृपया अन्य खोज का प्रयास करें
चिन्ह | एक्सचेंज | करेंसी | ||
---|---|---|---|---|
GILD34 | B3 | BRL | देरी | |
GILD | NASDAQ | USD | रियल टाइम | |
0QYQ | लंदन | USD | रियल टाइम | |
GILD | मेक्सिको | MXN | देरी | |
GGILD | मिलान | EUR | रियल टाइम | |
GILD | ट्रेडगेट | EUR | देरी | |
GILD | फ़्रंकफ़र्ट | EUR | देरी | |
GILD | Xetra | EUR | देरी | |
GILDm | ब्यूनस आयर्स | ARS | देरी | |
GILD | विएना | EUR | रियल टाइम | |
GILD | लिमा | USD | देरी |
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Daniel P. O'Day | 57 | 2019 | Chairman & CEO |
Paul Berg | 97 | 1998 | Member of Scientific Advisory Board |
Grace E. Colon | 56 | 2023 | Chairman of the Board |
Joel R. Huff | - | - | Chairperson of Scientific Advisory Board |
Kelly A. Kramer | 56 | 2016 | Independent Director |
Javier J. Rodriguez | 53 | 2020 | Independent Director |
Sandra J. Horning | 75 | 2020 | Independent Director |
Jeffrey A. Bluestone | 71 | 2020 | Independent Director |
Ted W. Love | 65 | 2024 | Independent Director |
Jacqueline K. Barton | 71 | 1989 | Independent Director |
Eugene R. Schiff | - | - | Member of the Scientific Advisory Board |
John W. Mellors | 86 | - | Member of the Scientific Advisory Board |
Harish M. Manwani | 71 | 2018 | Independent Director |
Eric J. Topol | 70 | - | Member of Scientific Advisory Board |
Robert A. Harrington | 63 | - | Member of the Scientific Advisory Board |
Paul E. Klotman | - | - | Member of the Scientific Advisory Board |
Francis V. Chisari | - | - | Member of the Scientific Advisory Board |
Robert T. Schooley | - | - | Member of the Scientific Advisory Board |
Nezam H. Afdhal | 67 | - | Member of Scientific Advisory Board |
Mark C. Genovese | - | - | Member of Scientific Advisory Board |
Malcolm MacCoss | 76 | - | Member of Scientific Advisory Board |
Anthony Welters | 69 | 2020 | Lead Independent Director |
Kenneth C. Anderson | 73 | - | Member of the Scientific Advisory Board |
Brian J. Druker | 68 | - | Member of the Scientific Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है